NGM Biopharmaceuticals Stock
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
Sign up today and learn more about NGM Biopharmaceuticals Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About NGM Biopharmaceuticals Stock
NGM Biopharmaceuticals, Inc. is a privately held drug discovery company committed to identifying transformational medicines that dramatically improve human health. Based on emerging human clinical and genetic observations, the Company has devised several innovative experimental approaches to discover new therapies for the treatment of metabolic and cardiovascular diseases. Our current focus is on the gastrointestinal endocrine system, with an aim to identify novel factors implicated in the pathogenesis of type 2 diabetes and the apparent resolution of this grievous disease in patients who have undergone gastric bypass surgery.
Vice President, Research
Vice President, Business Development
Aetna Wun Trombley
Vice President, Clinical Research
Chief Executive Officer
Executive Director, Research Operations
William J. Rieflin
Vice President CMC and Technical Operations
Senior Director, Protein Sciences
Founder, President and Chief Scientific Officer
TechCrunch - Jul, 8 2017These South Bay and Peninsula cities are raking in venture capital
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase